Don’t miss when CEO Linda Persson summarises the first quarter of 2024 in conjunction with the published quarterly report. We can confirm that NanoEcho once again leaves behind an eventful quarter, during which we have successfully reached several important milestones.
“During this quarter, we have achieved significant milestones in our efforts to improve rectal cancer diagnostics. Our significant business agreement with SPL Medical and the success of our health economic analysis model demonstrate our dedication to making a real difference in healthcare,” comments CEO Linda Persson.
Read the full report here: https://storage.mfn.se/455ac034-fc9e-4ba2-92d4-9a7027923fd8/nanoecho-ab-publ-kvartalsrapport-for-januari-mars-2024.pdf
